Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dipeptidyl-Peptidase 4 Inhibitors”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03608358
What this trial is testing

Safety and Efficacy of Dapagliflozin in Asian T2DM Subjects With Inadequate Glycemic Control on Metformin/Saxagliptin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 41
Large-scale testing (Phase 3)Ended earlyNCT00998686
What this trial is testing

Safety and Efficacy Study of Dutogliptin in Subjects With Type 2 Diabetes Mellitus on a Background Medication of Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Phenomix 650
Not applicableStudy completedNCT03500900
What this trial is testing

Vildagliptin on Gastric Accommodation

Who this might be right for
Healthy
Universitaire Ziekenhuizen KU Leuven 20
Testing effectiveness (Phase 2)Ended earlyNCT00370942
What this trial is testing

GW823093C For The Treatment Of Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 159
Not applicableStudy completedNCT04295005
What this trial is testing

A Study Based on Data From German Sick Funds That Looks at the Costs of Treatment of Type-2 Diabetic Patients With Empagliflozin vs. DPP-4 Inhibitors vs. GLP-1 Receptor Agonists

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 24,500
Testing effectiveness (Phase 2)UnknownNCT04419337
What this trial is testing

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Who this might be right for
Diabetes MellitusStroke
Chang Gung Memorial Hospital 200
Large-scale testing (Phase 3)Study completedNCT01137812
What this trial is testing

The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 756
Post-approval studies (Phase 4)Study completedNCT01744236
What this trial is testing

SAFEGUARD: Pleiotropic Effects of Incretin Based Therapies

Who this might be right for
Type 2 Diabetes
Amsterdam UMC, location VUmc 70
Post-approval studies (Phase 4)Study completedNCT02231021
What this trial is testing

The Practical Evidence of Antidiabetic Combination Therapy in Korea

Who this might be right for
Type 2 Diabetes Mellitus
Kun-Ho Yoon 216
Post-approval studies (Phase 4)Study completedNCT02442817
What this trial is testing

Linagliptin and Mesenchymal Stem Cells: A Pilot Study

Who this might be right for
Schizophrenia
University of Nevada, Reno 10
Post-approval studies (Phase 4)Looking for participantsNCT06399835
What this trial is testing

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 120
Early research (Phase 1)Study completedNCT05266404
What this trial is testing

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Who this might be right for
Healthy Volunteers (Intended Indication: Type 2 Diabetes Mellitus)
AstraZeneca 46
Testing effectiveness (Phase 2)Study completedNCT01155284
What this trial is testing

Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Sanford Health 70
Early research (Phase 1)Study completedNCT00888238
What this trial is testing

A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 12
Large-scale testing (Phase 3)WithdrawnNCT01038648
What this trial is testing

Sitagliptin in Prevention of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals
Post-approval studies (Phase 4)Study completedNCT02853630
What this trial is testing

A Clinical Trial to Study the Effects of Two Drugs, Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

Who this might be right for
TYpe 2 Diabetes Mellitus
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 203
Not applicableStudy completedNCT01272583
What this trial is testing

Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery

Who this might be right for
Type 1 DiabetesHypoglycemia
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 16
Not applicableStudy completedNCT05768945
What this trial is testing

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Who this might be right for
Diabetes
Brigham and Women's Hospital 742,670
Post-approval studies (Phase 4)Study completedNCT01845831
What this trial is testing

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Emory University 292
Post-approval studies (Phase 4)Study completedNCT02027753
What this trial is testing

Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 109
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation